Magnesium plus mexiletine inhibit energy usage and protect retinas against ischemia

Kenneth I. Maynard, Alfredo Quinones-Hinojosa, Christopher S. Ogilvy

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We determined whether exogenous Mg2+ and/or mexiletine (Mex), which are reported to be neuroprotective agents, reduced neuronal energy requirements and protected against ischemia, using isolated rabbit retinas. Under non-ischemic conditions, Mex (300 μM) and the combination of Mg2+ (1 mM) plus Mex (300 μM) significantly reduced glucose utilization, by 19% and 31%, respectively. The combination of Mg2+ plus Mex, but not either agent alone, significantly reduced lactate production (by 18%; p < 0.05). When added during 2 h of ischemia (simulated by the reduction of oxygen from 95% to 15% and of glucose from 6 mM to 1 mM), Mg2+ plus Mex improved the recovery of glucose utilization (p < 0.01), lactate production (p < 0.05) and neuronal function (p < 0.05) for 3 h following return to control (post- ischemia/recovery) conditions. Thus reducing energy demands by blocking functions during temporary ischemia, protects neurons from irreversible functional damage.

Original languageEnglish (US)
Pages (from-to)4141-4144
Number of pages4
JournalNeuroReport
Volume9
Issue number18
StatePublished - Dec 21 1998
Externally publishedYes

Fingerprint

Mexiletine
Magnesium
Retina
Ischemia
Glucose
Lactic Acid
Neuroprotective Agents
Oxygen
Rabbits
Neurons

Keywords

  • Energy metabolism
  • Ischemia
  • Metabolic inhibition
  • Neuroprotection
  • Stroke

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Magnesium plus mexiletine inhibit energy usage and protect retinas against ischemia. / Maynard, Kenneth I.; Quinones-Hinojosa, Alfredo; Ogilvy, Christopher S.

In: NeuroReport, Vol. 9, No. 18, 21.12.1998, p. 4141-4144.

Research output: Contribution to journalArticle

Maynard, Kenneth I. ; Quinones-Hinojosa, Alfredo ; Ogilvy, Christopher S. / Magnesium plus mexiletine inhibit energy usage and protect retinas against ischemia. In: NeuroReport. 1998 ; Vol. 9, No. 18. pp. 4141-4144.
@article{9277360cd8e2401b8204f5b89ceda7e0,
title = "Magnesium plus mexiletine inhibit energy usage and protect retinas against ischemia",
abstract = "We determined whether exogenous Mg2+ and/or mexiletine (Mex), which are reported to be neuroprotective agents, reduced neuronal energy requirements and protected against ischemia, using isolated rabbit retinas. Under non-ischemic conditions, Mex (300 μM) and the combination of Mg2+ (1 mM) plus Mex (300 μM) significantly reduced glucose utilization, by 19{\%} and 31{\%}, respectively. The combination of Mg2+ plus Mex, but not either agent alone, significantly reduced lactate production (by 18{\%}; p < 0.05). When added during 2 h of ischemia (simulated by the reduction of oxygen from 95{\%} to 15{\%} and of glucose from 6 mM to 1 mM), Mg2+ plus Mex improved the recovery of glucose utilization (p < 0.01), lactate production (p < 0.05) and neuronal function (p < 0.05) for 3 h following return to control (post- ischemia/recovery) conditions. Thus reducing energy demands by blocking functions during temporary ischemia, protects neurons from irreversible functional damage.",
keywords = "Energy metabolism, Ischemia, Metabolic inhibition, Neuroprotection, Stroke",
author = "Maynard, {Kenneth I.} and Alfredo Quinones-Hinojosa and Ogilvy, {Christopher S.}",
year = "1998",
month = "12",
day = "21",
language = "English (US)",
volume = "9",
pages = "4141--4144",
journal = "NeuroReport",
issn = "0959-4965",
publisher = "Lippincott Williams and Wilkins",
number = "18",

}

TY - JOUR

T1 - Magnesium plus mexiletine inhibit energy usage and protect retinas against ischemia

AU - Maynard, Kenneth I.

AU - Quinones-Hinojosa, Alfredo

AU - Ogilvy, Christopher S.

PY - 1998/12/21

Y1 - 1998/12/21

N2 - We determined whether exogenous Mg2+ and/or mexiletine (Mex), which are reported to be neuroprotective agents, reduced neuronal energy requirements and protected against ischemia, using isolated rabbit retinas. Under non-ischemic conditions, Mex (300 μM) and the combination of Mg2+ (1 mM) plus Mex (300 μM) significantly reduced glucose utilization, by 19% and 31%, respectively. The combination of Mg2+ plus Mex, but not either agent alone, significantly reduced lactate production (by 18%; p < 0.05). When added during 2 h of ischemia (simulated by the reduction of oxygen from 95% to 15% and of glucose from 6 mM to 1 mM), Mg2+ plus Mex improved the recovery of glucose utilization (p < 0.01), lactate production (p < 0.05) and neuronal function (p < 0.05) for 3 h following return to control (post- ischemia/recovery) conditions. Thus reducing energy demands by blocking functions during temporary ischemia, protects neurons from irreversible functional damage.

AB - We determined whether exogenous Mg2+ and/or mexiletine (Mex), which are reported to be neuroprotective agents, reduced neuronal energy requirements and protected against ischemia, using isolated rabbit retinas. Under non-ischemic conditions, Mex (300 μM) and the combination of Mg2+ (1 mM) plus Mex (300 μM) significantly reduced glucose utilization, by 19% and 31%, respectively. The combination of Mg2+ plus Mex, but not either agent alone, significantly reduced lactate production (by 18%; p < 0.05). When added during 2 h of ischemia (simulated by the reduction of oxygen from 95% to 15% and of glucose from 6 mM to 1 mM), Mg2+ plus Mex improved the recovery of glucose utilization (p < 0.01), lactate production (p < 0.05) and neuronal function (p < 0.05) for 3 h following return to control (post- ischemia/recovery) conditions. Thus reducing energy demands by blocking functions during temporary ischemia, protects neurons from irreversible functional damage.

KW - Energy metabolism

KW - Ischemia

KW - Metabolic inhibition

KW - Neuroprotection

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=0345471357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345471357&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 4141

EP - 4144

JO - NeuroReport

JF - NeuroReport

SN - 0959-4965

IS - 18

ER -